Quanterix Corp (QTRX) - Total Assets
Based on the latest financial reports, Quanterix Corp (QTRX) holds total assets worth $444.14 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See QTRX net asset value for net asset value and shareholders' equity analysis.
Quanterix Corp - Total Assets Trend (2015–2024)
This chart illustrates how Quanterix Corp's total assets have evolved over time, based on quarterly financial data.
Quanterix Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Quanterix Corp's total assets of $444.14 Million consist of 89.4% current assets and 10.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.0% |
| Accounts Receivable | $32.14 Million | 7.9% |
| Inventory | $32.77 Million | 8.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.03 Million | 1.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Quanterix Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Quanterix Corp.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Quanterix Corp's current assets represent 89.4% of total assets in 2024, an increase from 77.8% in 2015.
- Cash Position: Cash and equivalents constituted 14.0% of total assets in 2024, down from 31.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 8.1% of total assets.
Quanterix Corp Competitors by Total Assets
Key competitors of Quanterix Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Quanterix Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.02 | 10.07 | 5.52 |
| Quick Ratio | 2.31 | 9.16 | 5.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $155.93 Million | $330.51 Million | $179.80 Million |
Quanterix Corp - Advanced Valuation Insights
This section examines the relationship between Quanterix Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.87 |
| Latest Market Cap to Assets Ratio | 0.39 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | $406.53 Million |
| Market Capitalization | $158.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Quanterix Corp's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Quanterix Corp's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Quanterix Corp (2015–2024)
The table below shows the annual total assets of Quanterix Corp from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $406.53 Million | -5.14% |
| 2023-12-31 | $428.57 Million | -1.16% |
| 2022-12-31 | $433.58 Million | -14.40% |
| 2021-12-31 | $506.51 Million | +86.87% |
| 2020-12-31 | $271.05 Million | +59.48% |
| 2019-12-31 | $169.95 Million | +151.30% |
| 2018-12-31 | $67.63 Million | -26.31% |
| 2017-12-31 | $91.78 Million | +147.27% |
| 2016-12-31 | $37.12 Million | +404.92% |
| 2015-12-31 | $7.35 Million | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more